BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

8.53
Delayed Data
As of Mar 24
 +0.41 / +5.05%
Today’s Change
7.61
Today|||52-Week Range
18.00
-25.70%
Year-to-Date

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for BioCryst Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 30.00 and a low estimate of 8.00. The median estimate represents a +52.40% increase from the last price of 8.53.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in BioCryst Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.30
Sales
$71.1M
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 20.81%
 
 
 
 
 
 
Growthannually 24.31%
 
 
 
 
 
 

Sales

Growthquarterly -10.59%
 
 
 
 
 
 
Growthannually 20.81%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.